Valuation Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate Other stock markets 09:05:01 04/08/2026 +04			5-day change	1st Jan Change
58.75 ^EUR	+0.17%		-1.35%	-7.35%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,138	1,925	3,213	3,220	3,248	2,994	-	-
Change	-	-53.49%	66.93%	0.22%	0.87%	-7.81%	-	-
Enterprise Value (EV) ¹	4,112	1,872	3,251	3,305	3,272	2,978	2,913	2,801
Change	-	-54.48%	73.7%	1.65%	-1%	-8.97%	-2.19%	-3.84%
P/E	26.7x	9.67x	18.8x	23.6x	23.1x	20.9x	17.3x	14.1x
PBR	8.59x	3.71x	5.94x	5.63x	4.89x	4.01x	3.41x	2.92x
PEG	-	0.3x	-1.3x	-1.4x	7.71x	12.69x	0.8x	0.6x
Capitalization / Revenue	6.38x	2.35x	3.87x	4.22x	4.37x	3.88x	3.36x	3.07x
EV / Revenue	6.34x	2.29x	3.92x	4.33x	4.4x	3.86x	3.27x	2.87x
EV / EBITDA	20.3x	6.72x	13.3x	15.9x	15.1x	15.2x	11.3x	9.01x
EV / EBIT	22.7x	7.32x	14.8x	18.4x	17.6x	18.2x	13x	10.2x
EV / FCF	37.9x	10.1x	54.3x	43.5x	27.4x	16.2x	23.4x	17x
FCF Yield	2.64%	9.95%	1.84%	2.3%	3.65%	6.19%	4.27%	5.89%
Dividend per Share ²	0.9556	1.294	1.104	0.9351	0.9594	0.963	1.169	1.354
Rate of return	1.29%	3.59%	1.83%	1.49%	1.51%	1.64%	2%	2.31%
EPS ²	2.76	3.73	3.2	2.67	2.75	2.795	3.388	4.146
Distribution rate	34.6%	34.7%	34.5%	35%	34.9%	34.5%	34.5%	32.6%
Net sales ¹	648.7	817.7	829.5	763.7	743.5	771.7	890.8	976.1
EBITDA ¹	202.9	278.7	244.5	207.4	216.2	196.3	258.6	310.9
EBIT ¹	181.5	255.8	220.1	179.4	185.8	163.5	223.7	274.4
Net income ¹	153.1	199.7	170.3	136.9	140.4	128.5	173.9	212.8
Net Debt ¹	-25.87	-52.78	38.6	85.1	23.84	-16.21	-81.51	-193.5
Reference price ²	73.80	36.06	60.20	62.95	63.50	58.55	58.55	58.55
Nbr of stocks (in thousands)	56,069	53,375	53,370	51,149	51,149	51,143	-	-
Announcement Date	23/02/22	21/02/23	27/02/24	25/02/25	24/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.03x	12.19x	25.61x	0.59%	1T
JOHNSON & JOHNSON	27.48x	6.29x	17.54x	2.1%	613B
ABBVIE INC.	32.57x	7.42x	15.36x	2.76%	433B
ROCHE HOLDING AG	19.7x	4.68x	11.59x	2.83%	350B
NOVARTIS AG	22.21x	5.74x	14.32x	2.8%	292B
ASTRAZENECA PLC	21.76x	4.48x	12.7x	1.96%	239B
NOVO NORDISK A/S	13.48x	5.05x	10.4x	3.71%	206B
AMGEN INC.	25.29x	6.61x	11.66x	2.62%	204B
GILEAD SCIENCES, INC.	-46.92x	5.63x	31.08x	2.53%	163B
Average	16.73x	6.45x	16.70x	2.43%	388.94B
Weighted average by Cap.	24.25x	7.70x	18.25x	2.01%